The Latest Breaking News from Lilly

Insulin producers Eli Lilly, Novo Nordisk and Sanofi all reported losses during Friday’s trading

Twitter's new verification system shook Eli Lilly — leading LLY stock to skid Friday — after a fake account claimed "insulin is free now."

Despite the Fed’s continued hawkish stance, the September inflation report came in hotter than expected, raising the possibility of another aggressive interest rate hike in November. However, it could be smart to keep investing in quality stocks to benefit from their rebound. We think Microsoft (MSFT), Eli Lilly (LLY), and…

Biogen could easily take on Roche and Eli Lilly in Alzheimer's treatment, an analyst said Thursday as he upgraded Biogen stock.

Amgen stock surged Tuesday on a reportedly bullish call for its experimental obesity treatment — a potential rival to Novo and Lilly.

As the market tries to rebound, the best mutual funds bet big on 24 stocks including Vertex, Lilly and Enphase.

Eli Lilly said Thursday it plans to begin the process of asking the FDA to approve its obesity treatment. LLY stock rose on the news.

Dow Jones futures fell as Treasury yields rebounded, signaling Wednesday's rally may be short-lived. Eli Lilly leads some bullish stocks.

Bloomberg